Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,000
Closed -$839K 135
2025
Q3
$839K Buy
+25,000
New +$606K 0.3% 102
2025
Q1
Sell
-65,000
Closed -$1.3M 129
2024
Q4
$1.3M Buy
+65,000
New +$1.47M 0.44% 82
2023
Q4
Sell
-116,355
Closed -$4.14M 143
2023
Q3
$4.14M Sell
116,355
-22,675
-16% -$790K 1.41% 15
2023
Q2
$4.65M Buy
139,030
+7,336
+6% +$230K 1.48% 15
2023
Q1
$4.3M Buy
131,694
+25,694
+24% +$728K 1.39% 18
2022
Q4
$2.8M Buy
+106,000
New +$2.94M 0.79% 51
2022
Q2
Sell
-95,000
Closed -$4.71M 133
2022
Q1
$4.71M Buy
+95,000
New +$4.71M 0.89% 42
2021
Q1
Sell
-190,000
Closed -$9.47M 171
2020
Q4
$9.47M Buy
+190,000
New +$9.28M 1.58% 19

Other funds holding INTC

Formula Growth's INTC Position: Q4 2025 in Review

Formula Growth sold out of Intel (INTC) in Q4 2025, closing a stake of 25,000 shares — an estimated $839K sold.

Formula Growth first reported a position in INTC in Q4 2020 and held it in 8 quarters. The position peaked at $9.47M in Q4 2020. 2,434 funds tracked by Wall St. Rank hold INTC as of Q4 2025.

  • Formula Growth reported no remaining Intel position as of Q4 2025 after selling out during the quarter.
  • Formula Growth sold 25,000 Intel shares in Q4 2025, an estimated $839K.
  • Formula Growth first reported a position in Intel in Q4 2020 and held it in 8 quarters.
  • Formula Growth's Intel position peaked at $9.47M in Q4 2020.
  • 2,434 funds tracked by Wall St. Rank held Intel as of Q4 2025.

Based on Formula Growth's 13F filing for Q4 2025, filed 13 Feb 2026.